CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial...
Phase 2
Cincinnati, Ohio, United States and 15 other locations
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...
Phase 3
Cincinnati, Ohio, United States and 181 other locations
fulvestrant in patients with PIK3CA-mutated ER-positive endometrioid endometrial cancers by estimating the objective response rate ...
Phase 2
Kettering, Ohio, United States and 10 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Dayton, Ohio, United States and 202 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Cincinnati, Ohio, United States and 243 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Cincinnati, Ohio, United States and 243 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Cincinnati, Ohio, United States and 168 other locations
Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advance...
Phase 3
Centerville, Ohio, United States and 152 other locations
to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...
Phase 2
Cincinnati, Ohio, United States and 68 other locations
global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers...
Phase 2
Centerville, Ohio, United States and 44 other locations
Clinical trials
Research sites
Resources
Legal